Puromycin

Last updated
Puromycin
Puromycin skeletal.svg
Puromycin 3D spacefill.png
Names
IUPAC name
3′-Deoxy-N,N-dimethyl-3′-(O-methyl-L-tyrosinamido)adenosine
Systematic IUPAC name
(2S)-2-Amino-N-{(2S,3S,4R,5R)-5-[6-(dimethylamino)-9H-purin-9-yl]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl}-3-(4-methoxyphenyl)propanamide
Identifiers
3D model (JSmol)
ChEBI
ChEMBL
ChemSpider
DrugBank
KEGG
MeSH Puromycin
PubChem CID
UNII
  • InChI=1S/C22H29N7O5/c1-28(2)19-17-20(25-10-24-19)29(11-26-17)22-18(31)16(15(9-30)34-22)27-21(32)14(23)8-12-4-6-13(33-3)7-5-12/h4-7,10-11,14-16,18,22,30-31H,8-9,23H2,1-3H3,(H,27,32)/t14-,15+,16+,18+,22+/m0/s1 Yes check.svgY
    Key: RXWNCPJZOCPEPQ-NVWDDTSBSA-N Yes check.svgY
  • InChI=1/C22H29N7O5/c1-28(2)19-17-20(25-10-24-19)29(11-26-17)22-18(31)16(15(9-30)34-22)27-21(32)14(23)8-12-4-6-13(33-3)7-5-12/h4-7,10-11,14-16,18,22,30-31H,8-9,23H2,1-3H3,(H,27,32)/t14-,15+,16+,18+,22+/m0/s1
    Key: RXWNCPJZOCPEPQ-NVWDDTSBBO
  • O=C(N[C@@H]3[C@H](O[C@@H](n2cnc1c2ncnc1N(C)C)[C@@H]3O)CO)[C@@H](N)Cc4ccc(OC)cc4
Properties
C22H29N7O5
Molar mass 471.50956
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
X mark.svgN  verify  (what is  Yes check.svgYX mark.svgN ?)

Puromycin is an antibiotic protein synthesis inhibitor which causes premature chain termination during translation.

Contents

Inhibition of translation

Puromycin is an aminonucleoside antibiotic, derived from the Streptomyces alboniger bacterium, [1] that causes premature chain termination during translation taking place in the ribosome. Part of the molecule resembles the 3' end of the aminoacylated tRNA. It enters the A site and transfers to the growing chain, causing the formation of a puromycylated nascent chain and premature chain release. [2] The exact mechanism of action is unknown at this time but the 3' position contains an amide linkage instead of the normal ester linkage of tRNA. That makes the molecule much more resistant to hydrolysis and stops the ribosome.

Puromycin is selective for either prokaryotes or eukaryotes.

Also of note, puromycin is critical in mRNA display. In this reaction, a puromycin molecule is chemically attached to the end of an mRNA template, which is then translated into protein. The puromycin can then form a covalent link to the growing peptide chain allowing the mRNA to be physically linked to its translational product.

Antibodies that recognize puromycylated nascent chains can also be used to purify newly synthesized polypeptides [3] and to visualize the distribution of actively translating ribosomes by immunofluorescence. [4]

Peptidase Inhibitor

Puromycin is a reversible inhibitor of dipeptidyl-peptidase II (serine peptidase) and cytosol alanyl aminopeptidase (metallopeptidase). [5] [6] The mechanism of inhibition is not well understood, however puromycin can be used to distinguish between aminopeptidase M (active) and cytosol alanyl aminopeptidase (inhibited by puromycin).

Cell culture

Puromycin is used in cell biology as a selective agent in cell culture systems. It is toxic to prokaryotic and eukaryotic cells. Resistance to puromycin is conferred by the pac gene encoding a puromycin N-acetyl-transferase (PAC) that was found in a Streptomyces producer strain. Puromycin is soluble in water (50 mg/mL) as colorless solution at 10 mg/mL. Puromycin is stable for one year as solution when stored at -20 °C. The recommended dose as a selection agent in cell cultures is within a range of 1-10 μg/mL, although it can be toxic to eukaryotic cells at concentrations as low as 1 μg/mL. Puromycin acts quickly and can kill up to 99% of nonresistant cells within 2 days.[ citation needed ]

Selection of Escherichia coli

Puromycin is poorly active on E. coli. Puromycin-resistant transformants are selected in LB agar medium supplemented with 125 μg/mL of puromycin. But use of puromycin for E. coli selection requires precise pH adjustment and also depends on which strain is selected. For hassle–free selection and optimum results the use of specially modified puromycin is possible. Plates containing puromycin are stable for 1 month when stored at 4  [7] °C.[ citation needed ]

Selection of yeast

Puromycin resistance in yeast can also be conferred through expression of the puromycin N-acetyl-transferase (pac) gene. [8] Lethal concentrations of puromycin are much higher for strains of Saccharomyces cerevisiae than mammalian cell lines. Deletion of the gene encoding the multidrug efflux pump Pdr5 sensitizes cells to puromycin.[ citation needed ]

Memory loss in mice

Long-term synaptic plasticity, such as is required for memory processes, requires morphological changes at protein level. As puromycin inhibits protein synthesis in eukaryotic cells, researchers were able to show that injections of this drug will result in both short-term as well as long-term memory loss in mice. [9]

Related Research Articles

Protein targeting or protein sorting is the biological mechanism by which proteins are transported to their appropriate destinations within or outside the cell. Proteins can be targeted to the inner space of an organelle, different intracellular membranes, the plasma membrane, or to the exterior of the cell via secretion. Information contained in the protein itself directs this delivery process. Correct sorting is crucial for the cell; errors or dysfunction in sorting have been linked to multiple diseases.

<span class="mw-page-title-main">Ribosome</span> Synthesizes proteins in cells

Ribosomes are macromolecular machines, found within all cells, that perform biological protein synthesis. Ribosomes link amino acids together in the order specified by the codons of messenger RNA molecules to form polypeptide chains. Ribosomes consist of two major components: the small and large ribosomal subunits. Each subunit consists of one or more ribosomal RNA molecules and many ribosomal proteins. The ribosomes and associated molecules are also known as the translational apparatus.

<span class="mw-page-title-main">Translation (biology)</span> Cellular process of protein synthesis

In biology, translation is the process in living cells in which proteins are produced using RNA molecules as templates. The generated protein is a sequence of amino acids. This sequence is determined by the sequence of nucleotides in the RNA. The nucleotides are considered three at a time. Each such triple results in addition of one specific amino acid to the protein being generated. The matching from nucleotide triple to amino acid is called the genetic code. The translation is performed by a large complex of functional RNA and proteins called ribosomes. The entire process is called gene expression.

A signal peptide is a short peptide present at the N-terminus of most newly synthesized proteins that are destined toward the secretory pathway. These proteins include those that reside either inside certain organelles, secreted from the cell, or inserted into most cellular membranes. Although most type I membrane-bound proteins have signal peptides, most type II and multi-spanning membrane-bound proteins are targeted to the secretory pathway by their first transmembrane domain, which biochemically resembles a signal sequence except that it is not cleaved. They are a kind of target peptide.

<span class="mw-page-title-main">Cycloheximide</span> Chemical compound

Cycloheximide is a naturally occurring fungicide produced by the bacterium Streptomyces griseus. Cycloheximide exerts its effects by interfering with the translocation step in protein synthesis, thus blocking eukaryotic translational elongation. Cycloheximide is widely used in biomedical research to inhibit protein synthesis in eukaryotic cells studied in vitro. It is inexpensive and works rapidly. Its effects are rapidly reversed by simply removing it from the culture medium.

Bacterial translation is the process by which messenger RNA is translated into proteins in bacteria.

Eukaryotic translation is the biological process by which messenger RNA is translated into proteins in eukaryotes. It consists of four phases: initiation, elongation, termination, and recapping.

<i>N</i>-Formylmethionine Chemical compound

N-Formylmethionine is a derivative of the amino acid methionine in which a formyl group has been added to the amino group. It is specifically used for initiation of protein synthesis from bacterial and organellar genes, and may be removed post-translationally.

<span class="mw-page-title-main">Dipeptidyl peptidase-4</span> Mammalian protein found in humans

Dipeptidyl peptidase-4, also known as adenosine deaminase complexing protein 2 or CD26 is a protein that, in humans, is encoded by the DPP4 gene. DPP4 is related to FAP, DPP8, and DPP9. The enzyme was discovered in 1966 by Hopsu-Havu and Glenner, and as a result of various studies on chemism, was called dipeptidyl peptidase IV [DP IV].

Protein metabolism denotes the various biochemical processes responsible for the synthesis of proteins and amino acids (anabolism), and the breakdown of proteins by catabolism.

mRNA display

mRNA display is a display technique used for in vitro protein, and/or peptide evolution to create molecules that can bind to a desired target. The process results in translated peptides or proteins that are associated with their mRNA progenitor via a puromycin linkage. The complex then binds to an immobilized target in a selection step. The mRNA-protein fusions that bind well are then reverse transcribed to cDNA and their sequence amplified via a polymerase chain reaction. The result is a nucleotide sequence that encodes a peptide with high affinity for the molecule of interest.

<span class="mw-page-title-main">Eukaryotic translation termination factor 1</span> Protein-coding gene in the species Homo sapiens

Eukaryotic translation termination factor1 (eRF1), also referred to as TB3-1 or SUP45L1, is a protein that is encoded by the ERF1 gene. In Eukaryotes, eRF1 is an essential protein involved in stop codon recognition in translation, termination of translation, and nonsense mediated mRNA decay via the SURF complex.

Elongation factor 4 (EF-4) is an elongation factor that is thought to back-translocate on the ribosome during the translation of RNA to proteins. It is found near-universally in bacteria and in eukaryotic endosymbiotic organelles including the mitochondria and the plastid. Responsible for proofreading during protein synthesis, EF-4 is a recent addition to the nomenclature of bacterial elongation factors.

<span class="mw-page-title-main">DPP3</span> Protein-coding gene in the species Homo sapiens

Dipeptidyl-peptidase 3 is an enzyme that in humans is encoded by the DPP3 gene.

<span class="mw-page-title-main">EIF2A</span> Protein-coding gene in the species Homo sapiens

Eukaryotic translation initiation factor 2A (eIF2A) is a protein that in humans is encoded by the EIF2A gene. The eIF2A protein is not to be confused with eIF2α, a subunit of the heterotrimeric eIF2 complex. Instead, eIF2A functions by a separate mechanism in eukaryotic translation.

<span class="mw-page-title-main">DPP7</span> Protein-coding gene in the species Homo sapiens

Dipeptidyl-peptidase 2 is an enzyme that in humans is encoded by the DPP7 gene.

<span class="mw-page-title-main">NPEPPS</span> Protein-coding gene in the species Homo sapiens

Puromycin-sensitive amino peptidase also known as cytosol alanyl aminopeptidase or alanine aminopeptidase (AAP) is an enzyme that in humans is encoded by the NPEPPS gene. It is used as a biomarker to detect damage to the kidneys, and that may be used to help diagnose certain kidney disorders. It is found at high levels in the urine when there are kidney problems.

<span class="mw-page-title-main">Protein synthesis inhibitor</span> Inhibitors of translation

A protein synthesis inhibitor is a compound that stops or slows the growth or proliferation of cells by disrupting the processes that lead directly to the generation of new proteins.

<span class="mw-page-title-main">Eukaryotic ribosome</span> Large and complex molecular machine

Ribosomes are a large and complex molecular machine that catalyzes the synthesis of proteins, referred to as translation. The ribosome selects aminoacylated transfer RNAs (tRNAs) based on the sequence of a protein-encoding messenger RNA (mRNA) and covalently links the amino acids into a polypeptide chain. Ribosomes from all organisms share a highly conserved catalytic center. However, the ribosomes of eukaryotes are much larger than prokaryotic ribosomes and subject to more complex regulation and biogenesis pathways. Eukaryotic ribosomes are also known as 80S ribosomes, referring to their sedimentation coefficients in Svedberg units, because they sediment faster than the prokaryotic (70S) ribosomes. Eukaryotic ribosomes have two unequal subunits, designated small subunit (40S) and large subunit (60S) according to their sedimentation coefficients. Both subunits contain dozens of ribosomal proteins arranged on a scaffold composed of ribosomal RNA (rRNA). The small subunit monitors the complementarity between tRNA anticodon and mRNA, while the large subunit catalyzes peptide bond formation.

<span class="mw-page-title-main">Signal peptidase</span>

Signal peptidases are enzymes that convert secretory and some membrane proteins to their mature or pro forms by cleaving their signal peptides from their N-termini.

References

  1. Puromycin from PubChem
  2. Pestka, S. (1971). "Inhibitors of ribosome functions". Annu. Rev. Microbiol. 25: 487–562. doi:10.1146/annurev.mi.25.100171.002415. PMID   4949424.
  3. Eggers DK, Welch WJ, Hansen WJ (1997). "Complexes between nascent polypeptides and their molecular chaperones in the cytosol of mammalian cells". Mol Biol Cell. 8 (8): 1559–1573. doi:10.1091/mbc.8.8.1559. PMC   276176 . PMID   9285825.
  4. Starck SR, Green HM, Alberola-Ila J, Roberts RW (2004). "A general approach to detect protein expression in vivo using fluorescent puromycin conjugates". Chem. Biol. 11 (7): 999–1008. doi: 10.1016/j.chembiol.2004.05.011 . PMID   15271358.
  5. Dando, Pam M.; Young, Nina E.; Barrett, Alan J. (1997). "Aminopeptidase PS: a Widely Distributed Cytosolic Peptidase". In Hopsu-Havu, Väinö K.; Järvinen, Mikko; Kirschke, Heidrun (eds.). Proteolysis in Cell Functions. IOS Press. pp. 88–95. ISBN   978-90-5199-322-6.
  6. McDonald JK, Reilly TJ, Zeitman BB, Ellis S (1968). "Dipeptidyl arylamidase II of the pituitary. Properties of lysylalanyl-beta-naphthylamide hydrolysis: inhibition by cations, distribution in tissues, and subcellular localization". The Journal of Biological Chemistry. 243 (8): 2028–37. doi: 10.1016/S0021-9258(18)93545-3 . PMID   5646493.
  7. "Puromycin.com - Working concentrations (Protocols)". Archived from the original on 2014-10-10. Retrieved 2014-05-11.
  8. MacDonald C, Piper RC (2015). "Puromycin- and methotrexate-resistance cassettes and optimized Cre-recombinase expression plasmids for use in yeast". Yeast. 32 (5): 423–38. doi:10.1002/yea.3069. PMC   4454448 . PMID   25688547.
  9. Flexner, J. B.; Flexner, L. B.; Stellar, E. (1963-07-05). "Memory in mice as affected by intracerebral puromycin". Science. 141 (3575): 57–59. Bibcode:1963Sci...141...57F. doi:10.1126/science.141.3575.57. ISSN   0036-8075. PMID   13945541. S2CID   29071662.